Premium
Preventive effect of an E. coli ‐filtrate (Colibiogen®) in polymorphous light eruption
Author(s) -
PRZYBILLA B.,
HEPPELER M.,
RUZICKA T.
Publication year - 1989
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1989.tb01803.x
Subject(s) - drug eruption , medicine , dermatology , drug , pharmacology
SUMMARY During the administration of Colibiogen®, a commercially available E. coli‐filtrate, there was a significant ( P <0.01) increase of the test dose of UVA necessary to elicit skin lesions in nine patients with polymorphous light eruptions. Control tests performed in the same manner without the drug indicate that this was due to treatment. Colibiogen® appears to be of value in the treatment of polymorphous light eruption (PLE).